CARES

Cabotegravir And Rilpivirine: Efficacy and Safety Study

Aga Khan

Aga Khan University Hospital (AKUH) is located in Nairobi, Kenya.

It is a Private Not-For-Profit hospital and over the last 60 years, AKUH, Nairobi has been a leading provider of high-quality, comprehensive healthcare services and modern medical education in the East African region. The hospital boasts of 50 medical and diagnostic centres through East Africa which provide primary and specialized care and diagnostic services. As a teaching hospital, AKUH uses an evidence-based approach to medical training which is driven by cutting-edge research conducted by its highly-experienced faculty members.

The Department of Medicine is chaired by Prof. Reena Shah, who is the Site Principal Investigator for the CARES study at AKUH. The Infectious Diseases (ID) section within the department provides a range of services including but not limited to: a daily ID clinic that manages Sexually Transmitted Infections (STI’s), malaria and HIV; a free antiretroviral therapy (ART) clinic and a state-of-the-art microbiology laboratory with the capability to perform various specialised tests. The ID section also contributes to the infection control program at the hospital to enhance patient care and safety.​

The CARES study participants were recruited from regular clients who have been receiving their HIV care and treatment from the hospital.

Prof. Reena Shah
Site PI